Age Adjustments
Part of Pharmacy and Apothecary
How to adjust medication doses for patients at different life stages — infants, children, the elderly, and pregnant women — because standard adult doses can be lethal in vulnerable populations.
Why This Matters
A dose that is therapeutic for a healthy adult may be lethal for a newborn, mildly effective for a large teenager, or dangerously toxic for a frail 80-year-old. This is not merely a pharmacological detail — it is the difference between healing and harming. The history of medicine includes many tragedies caused by applying adult doses to children without adjustment, or failing to recognize that the elderly metabolize drugs differently.
In a rebuilding context, this knowledge is critical for anyone dispensing herbal preparations, natural medicines, or any active pharmaceutical compound. Without calibrated dosing by age and body characteristics, the same preparation can heal or kill depending on who receives it.
The underlying reason doses vary with age is physiological: infants have immature metabolic pathways, different body composition (more water, less fat, more permeable blood-brain barrier), and different kidney and liver function. The elderly have declining kidney and liver function, reduced total body water, and often multiple conditions that interact with medications.
Pediatric Dosing Principles
Children are not small adults. Their pharmacokinetics (how the body handles drugs) differ from adults in multiple ways:
Absorption: Gastric pH in infants is higher (less acidic) than adults, which affects absorption of some drugs. Skin absorption is higher in neonates due to thinner stratum corneum.
Distribution: Neonates have higher total body water (75-80% of body weight vs 60% in adults), which increases the volume of distribution for water-soluble drugs. Lower body fat in infants means reduced storage capacity for fat-soluble drugs. The blood-brain barrier is more permeable in neonates — drugs that do not cross in adults may reach the brain more easily in infants.
Metabolism: Liver enzyme systems (especially cytochrome P450 enzymes) are immature in neonates and develop over the first months to years. Some drugs metabolized by these enzymes are cleared much more slowly in neonates.
Excretion: Kidney function matures over the first 1-2 years. Glomerular filtration rate at birth is about 25-40% of adult values, reaching adult levels by 1-2 years.
Weight-Based Dosing
The most common approach: dose is expressed as mg per kg of body weight per day.
Example: An adult dose of 500 mg/day (for a 70 kg adult = 7 mg/kg/day) would be adjusted for a 20 kg child to 140 mg/day, and for a 5 kg infant to 35 mg/day.
This is the starting point for most pediatric dosing. However, it is not always correct — metabolic rates do not scale linearly with weight, especially in very young infants.
Body Surface Area Method
More accurate for some drugs: Dose (child) = Dose (adult) × (Child’s BSA / 1.73 m²)
BSA (m²) ≈ √(height in cm × weight in kg / 3600)
For a 10 kg, 75 cm toddler: BSA = √(75 × 10 / 3600) = √0.208 = 0.46 m² Child dose = Adult dose × 0.46/1.73 = Adult dose × 0.27
So a toddler this size would receive about 27% of the adult dose by surface area — compared to 14% by weight (10/70). Surface area scaling gives higher doses per kg for small children than weight-based alone, reflecting their higher metabolic rate.
Age-Based Rules of Thumb
These are rough guides only — use weight-based dosing when possible:
Young’s Rule (for ages 2-12): Child dose = (Age / (Age + 12)) × Adult dose
Age 4: 4/16 = 0.25 → 25% of adult dose Age 8: 8/20 = 0.40 → 40% of adult dose Age 12: 12/24 = 0.50 → 50% of adult dose
Fried’s Rule (for infants under 2 years): Infant dose = (Age in months / 150) × Adult dose
6-month infant: 6/150 = 0.04 → 4% of adult dose
Neonates and young infants
For infants under 3 months, no simple rule is reliable. Immature liver and kidney function mean that even “appropriate” doses based on weight or age may accumulate to toxic levels. For strong medicines, the default should be avoidance unless medically critical, with the lowest possible dose and close monitoring.
Pediatric Dose Limits by Age Group
| Age Group | Approximate % of Adult Dose | Notes |
|---|---|---|
| Premature neonate | 5-10% | Extreme caution; avoid strong drugs |
| Full-term neonate (0-1 mo) | 5-10% | Immature metabolism |
| Infant (1-12 months) | 10-25% | Improving but still immature kidney/liver |
| Toddler (1-3 years) | 25-35% | Weight-based dosing preferred |
| Child (3-7 years) | 35-50% | Weight-based dosing |
| Child (7-12 years) | 50-75% | Approaching adult-like metabolism |
| Adolescent (>12 years) | 75-100% | Use adult dose for large adolescents |
Geriatric Dosing Principles
Aging produces predictable pharmacokinetic changes:
Decreased renal function: Kidney filtration declines approximately 1% per year after age 40. By age 80, many individuals have 50% of their young-adult kidney function even without detectable kidney disease. Drugs cleared primarily by kidneys (including many antibiotics, digoxin, and lithium) accumulate at standard doses.
Decreased hepatic metabolism: Liver blood flow decreases and some metabolic enzyme activity declines with age. Drugs with high first-pass metabolism (removed extensively by the liver before entering systemic circulation) reach higher blood levels in elderly people.
Altered body composition: Decreased muscle mass, decreased total body water, and increased body fat. Water-soluble drugs distribute to a smaller volume (higher peak concentrations); fat-soluble drugs have higher volumes of distribution and longer half-lives.
Reduced serum albumin: Many drugs are protein-bound in plasma; lower albumin increases the free (active) fraction of highly protein-bound drugs.
Multiple medications: Elderly people often take multiple drugs simultaneously. The risk of drug-drug interactions increases with each additional medication.
Reduced homeostatic reserve: The elderly cannot compensate for drug effects as well as the young. A mildly sedating dose that causes slight drowsiness in a 30-year-old may cause falls, confusion, and respiratory depression in a 75-year-old.
Practical Elderly Dosing Principles
“Start low, go slow”: Begin with 25-50% of the standard adult dose. Increase gradually if needed.
Renal dose adjustment: For drugs cleared by kidneys, estimate kidney function from age alone if laboratory testing is unavailable:
- Ages 65-75: use 75% of standard dose
- Ages 75-85: use 50-60% of standard dose
- Ages >85: use 50% of standard dose, or avoid if possible
Avoid anticholinergic drugs (drugs blocking acetylcholine receptors) in the elderly: these cause confusion, constipation, urinary retention, and falls even at doses well-tolerated by younger adults. Many herbal preparations have anticholinergic properties (some nightshade-family plants).
Sedation sensitivity: The elderly are far more sensitive to sedatives, opioids, and sleep-inducing compounds. Standard doses cause respiratory depression and falls. Use 25-30% of standard sedative doses as starting point.
Pregnancy and Lactation
Pregnancy: The fetus is exposed to virtually all substances in the maternal bloodstream that cross the placenta — and most do. The first trimester (weeks 1-12) is the period of organogenesis when drug teratogenicity (birth defect causation) is highest. The general principle: avoid all non-essential medications during pregnancy, especially in the first trimester. When treatment is necessary, choose agents with the longest and most reassuring safety record.
Specific concerns:
- Many herbal preparations are traditionally used as abortifacients (pennyroyal, blue cohosh, tansy, mugwort, large-dose parsley, large-dose ginger)
- High-dose vitamin A (from liver or supplements) is teratogenic
- Aspirin in late pregnancy risks bleeding at delivery and premature closure of the ductus arteriosus
- Tetracycline-type antibiotics stain developing teeth
- Strong laxatives and cathartic herbs may stimulate uterine contractions
Lactation: Breast milk contains most substances in the maternal bloodstream. The infant dose through milk depends on the mother’s blood level and the milk:plasma ratio of the specific drug. Highly lipid-soluble compounds (lipophilic drugs, alcohol, some herbal alkaloids) transfer more readily. The infant receives a fraction of the mother’s dose — usually 1-5% of the mother’s weight-adjusted dose — but this may be significant for young infants with immature metabolism.
Documentation and Community Practice
A community dispensary should maintain records of:
- Patient age and weight at time of treatment
- Dose given and calculation method used
- Clinical response and any adverse effects
These records allow pattern recognition over time — identifying preparations that are problematic in certain age groups and building a local pharmacopoeia that reflects actual observed outcomes rather than theory alone. This is how historical apothecaries refined their practice: systematic observation recorded and shared.
Practical standard: when in doubt, halve the dose
In the absence of specific information for a vulnerable patient (young infant, frail elderly, first trimester pregnancy), cutting the dose by half and monitoring for effect before considering additional doses is a reasonable conservative strategy that prevents most dose-related harm.